FDA Expectations for Natural History Evidence in Rare Disease Trials
FDA Expectations for Natural History Evidence in Rare Disease Trials Meeting FDA Expectations for Natural History Data in Rare Disease Development Introduction: The Regulatory Role of Natural History in Rare Diseases Natural history studies have become a regulatory cornerstone in the development of therapies for rare diseases. The U.S. Food and Drug Administration (FDA) recognizes…
Read More “FDA Expectations for Natural History Evidence in Rare Disease Trials” »